on 8 Feb 2024
Last Applicant/ Owned by
Amylyx Pharmaceuticals, Inc.
43 Thorndike StreetCambridge MA 02141
US
Serial Number
2309614 filed on 10th Jan 2024
Correspondent Address
SMART & BIGGAR LP
SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA
ONTARIO
CA
K1P5Y6
Trademark usage description
pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals.12
2309614
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 14th Jan 2025 | Agent Changed |
Submitted for opposition 256 on 9th Dec 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 8th Feb 2024 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 8th Feb 2024 | Formalized |
Submitted for opposition 1 on 8th Feb 2024 | Created |
Submitted for opposition 30 on 10th Jan 2024 | Filed |
Submitted for opposition 228 on 10th Jan 2024 | International Registration |